Amid the Crowdstrike global outage, we are manually processing transactions and prioritizing clients with urgent disbursements planned for today. We invite our clients with time sensitive transactions to contact their BDC representatives directly for more information.

Amid the Crowdstrike global outage, we are manually processing transactions and prioritizing clients with urgent disbursements planned for today. We invite our clients with time sensitive transactions to contact their BDC representatives directly for more information.

Mimosa Diagnostics logo
Portfolio company

Mimosa Diagnostics

Details
Region
Ontario
Industry sector
Medical/health
Investment year
2018
Fund
Women in Technology Venture Fund
Learn more
About the company

MIMOSA Diagnostics is a leading mHealth innovator building the next generation of patient monitoring and assessment tools. Driven by AI and delivered through the cloud, MIMOSA uses multi-spectral mobile tissue analysis to go beyond anatomy and assess the physiology of tissue health. Through real-time insights into tissue conditions and viability, MIMOSA improves remote monitoring and assessment, enabling better treatment decisions and outcomes for each patient.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.